# Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease

> **NCT00774969** · PHASE1 · COMPLETED · sponsor: **S.L.A. Pharma AG** · enrollment: 19 (actual)

## Conditions studied

- Perianal Crohns'

## Interventions

- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT00774969
- **Lead sponsor:** S.L.A. Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2008-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774969, "Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00774969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*